NPHCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
NUTRA PHARMA CORP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$0.00+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $806.69K
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Nutra Pharma has not reported a dividend
No dividend per share appears in Nutra Pharma's annual filings since fiscal 2010.